Incentives, Organization, and Financing
Technological change in healthcare has led to huge improvements in health services and the health status of populations. Although offering remarkable benefits, these changes often entail significant financial, physical and social risks. This book analyses the impact of advances in medical technology from an economic perspective.
Technological change in healthcare has led to huge improvements in health services and the health status of populations. It is also pinpointed as the main driver of healthcare expenditure. Although offering remarkable benefits, changes in technology are not free and often entail significant financial, as well as physical or social risks. These need to be balanced out in the setting of government regulations, insurance contracts, and individuals' decisions to use and consume certain technologies. With this in mind, this book addresses the following important objectives: to provide a detailed analysis of what technological change is; to identify drivers of innovation in several healthcare areas; to present existing mechanisms and processes for ensuring and valuing efficiency and development in the use of medical technologies; and to analyse the impact of advances in medical technology on health, healthcare expenditure, and health insurance.; Each of the seventeen chapters summarizes an important issue concerning the innovation debate and contributes to a better understanding of the role innovation has both at the macro level and at the delivery (meso) and micro level in the healthcare sector. The effectiveness of innovation in improving people's welfare depends on its diffusion and inception by the relevant agents in the health production process, and this book recognizes the multi-faceted contribution of policy makers, regulators, managers, technicians, consumers and patients to this technology change. This book offers the first truly global economic analysis of healthcare technologies, taking the subject beyond simply economic evaluation, and exploring the behavioural aspects, organization and incentives for new technology developments, and the adoption and diffusion of these technologies.
PART I. INTRODUCTION; 1. What do we know about the role of health care technology in driving healthcare expenditure growth?; PART II. INNOVATION, DIFFUSION AND TECHNOLOGY CHANGE; 2. The process of innovation: incentives, behaviour and organization; 3. Technology - scientific force or power force?; 4. Diffusion of health technologies: evidence from the pharmaceutical sector; PART III. TECHNOLOGICAL CHANGE AND HEALTH INSURANCE; 5. Insurance and new health technology; 6. Technological change and health insurance; 7. Health insurance and the uptake of new drugs in the United States; 8. Genetic advances and health insurance; PART IV. INNOVATION, SOCIAL DEMAND AND VALUATION; 9. Ageing and pharmaceutical innovation; 10. New approaches to healthcare innovation: information for chronic patients; 11. The convergence of nano-, bio- and information technologies in healthcare; 12. Treatment uncertainty and irreversibility in medical care: implications for cost-effectiveness analysis; 13. The limits and challenges to the economic evaluation of health technologies; PART V. INCENTIVES, MECHANISMS AND PROCESSES; 14. Intellectual property rights and pharmaceuticals development; 15. Home, or nursing home? The effect of medical innovation on the demand for long-term care; 16. Demand for health information on the internet; 17. Institutional pathways for integrating genetic testing into mainstream healthcare